AstraZeneca (AZN)

Share price graph

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 5004.00p Today's change: -0.44%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 5004.00p 5 day change: -2.63%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 5004.00p 6 month change: +28.79%

Contact details

Address: 2 Kingdom Street, London
Phone: +44 (0)20 7604 8000
Fax: +44 (0)20 7604 8151
Website: www.astrazeneca.com

Company information

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

Shares in Cambridge-based pharma firm Sareum have shot up by 130 per cent after it announced its up-coming cancer [...]

27 September 2016
Views
124

Here are today's top stories from across the papers: [...]

22 September 2016
Views
330

Big pharma firm AstraZeneca has been forced to withdraw a marketing application for a new cancer drug, due [...]

21 September 2016
Views
104

Some of the world's biggest pharma firms have pledged to crack down on pollution and curb overuse of antibiotics.  [...]

20 September 2016
Shares
1
Views
79

AstraZeneca will pay $5.5m (£4.1m) to resolve a foreign bribery probe in the US. [...]

31 August 2016
Shares
4
Views
87

It's another scorcher in London and the FTSE 100 is feeling the heat, though European markets are broadly mixed [...]

24 August 2016
Views
49

Astrazeneca has agreed to sell one of its antibiotics businesses to American rival Pfizer in deal that could [...]

24 August 2016
Views
138

Shares in Brussels-based drugmaker UCB surged yesterday following a US ruling that blocks rival firms from making [...]

16 August 2016
Shares
9
Views
103

Cambridge-based pharma firm AstraZeneca has suffered a set back after a new cancer drug failed at the trial [...]

9 August 2016
Views
307

Pharmaceutical giant AstraZeneca today reported a fall in revenue driven by increased competition in the US cholesterol-fighting [...]

28 July 2016
Views
202

The long-awaited takeover of SAB Miller has reportedly been left on a knife edge by growing shareholder concerns [...]

24 July 2016
Views
401

The European Commission has granted marketing authorisation for pharmaceutical giant AstraZeneca for a new antibiotic. [...]

28 June 2016
Views
356

Top bosses at firms such as GlaxoSmithKline, AstraZeneca and Pfizer are among more than 90 leaders in the life sciences [...]

8 May 2016
Shares
91
Views
3,820

Profits have dropped at pharmaceutical giant AstraZeneca as the company ramped up its spending on research and [...]

29 April 2016
Views
250

The revolts came on the back of major uprisings at oil giant BP, miner Anglo American, energy firm Centrica and [...]

28 April 2016
Shares
4
Views
611

Content tagged with "AstraZeneca"